NCT00383526View on ClinicalTrials.gov

Study of Inactivated, Split-Virion Influenza Vaccine Compared With the Reference Vaccine Vaxigrip® in the Elderly

PHASE3CompletedINTERVENTIONAL
Enrollment

3,707

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

June 30, 2009

Study Completion Date

September 30, 2009

Conditions
Orthomyxoviridae InfectionInfluenzaMyxovirus Infection
Interventions
BIOLOGICAL

Inactivated, split-virion influenza vaccine

Vaccine

BIOLOGICAL

Inactivated, split-virion influenza vaccine

Vaccine

Trial Locations (4)

2060

Antwerp

16132

Genova

49000

Angers

LT-08117

Vilnius

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT00383526 - Study of Inactivated, Split-Virion Influenza Vaccine Compared With the Reference Vaccine Vaxigrip® in the Elderly | Biotech Hunter | Biotech Hunter